648 related articles for article (PubMed ID: 15315795)
1. Impact of beta globin gene mutations on the clinical phenotype of beta thalassemia in India.
Colah R; Nadkarni A; Gorakshakar A; Phanasgaonkar S; Surve R; Subramaniam PG; Bondge N; Pujari K; Ghosh K; Mohanty D
Blood Cells Mol Dis; 2004; 33(2):153-7. PubMed ID: 15315795
[TBL] [Abstract][Full Text] [Related]
2. Molecular, hematological and clinical aspects of thalassemia major and thalassemia intermedia associated with Hb E-beta-thalassemia in Northeast Thailand.
Nuntakarn L; Fucharoen S; Fucharoen G; Sanchaisuriya K; Jetsrisuparb A; Wiangnon S
Blood Cells Mol Dis; 2009; 42(1):32-5. PubMed ID: 18951049
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of beta-globin gene mutations among thalassemia patients in the West Bank region of Palestine.
Darwish HM; El-Khatib FF; Ayesh S
Hemoglobin; 2005; 29(2):119-32. PubMed ID: 15921164
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of β-thalassemia in the United Arab Emirates.
Baysal E
Hemoglobin; 2011; 35(5-6):581-8. PubMed ID: 22074124
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of beta-thalassemia mutations and their association with allelic sequence polymorphisms at the beta-globin gene cluster in an Eastern Indian population.
Kukreti R; Dash D; E VK; Chakravarty S; Das SK; De M; Talukder G
Am J Hematol; 2002 Aug; 70(4):269-77. PubMed ID: 12210807
[TBL] [Abstract][Full Text] [Related]
6. Study of beta-Thalassemia mutations using the polymerase chain reaction-amplification refractory mutation system and direct DNA sequencing techniques in a group of Egyptian Thalassemia patients.
El-Gawhary S; El-Shafie S; Niazi M; Aziz M; El-Beshlawy A
Hemoglobin; 2007; 31(1):63-9. PubMed ID: 17365006
[TBL] [Abstract][Full Text] [Related]
7. Molecular heterogeneity of beta-thalassemia in Thailand.
Fukumaki Y; Fucharoen S; Fucharoen G; Okamoto N; Ichinose M; Jetsrisuparb A; Sriroongrueng W; Nopparatana C; Laosombat V; Panich V
Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():14-21. PubMed ID: 1363706
[TBL] [Abstract][Full Text] [Related]
8. The molecular pathology of beta-thalassemia in Turkey: the Boğaziçi university experience.
Basak AN
Hemoglobin; 2007; 31(2):233-41. PubMed ID: 17486506
[TBL] [Abstract][Full Text] [Related]
9. The spectrum of beta-thalassemia mutations in southern Thailand.
Nopparatana C; Panich V; Saechan V; Sriroongrueng V; Nopparatana C; Rungjeadpha J; Pornpatkul M; Laosombat V; Fukumaki Y
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():229-34. PubMed ID: 8629112
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of beta-thalassemia in South Vietnam.
Svasti S; Hieu TM; Munkongdee T; Winichagoon P; Van Be T; Van Binh T; Fucharoen S
Am J Hematol; 2002 Oct; 71(2):85-8. PubMed ID: 12353305
[TBL] [Abstract][Full Text] [Related]
11. Variable clinical severity of Hb E beta-thalassemia among Indians.
Nadkarni A; Ghosh K; Gorakshakar A; Colah R; Mohanty D
J Assoc Physicians India; 1999 Oct; 47(10):966-8. PubMed ID: 10778688
[TBL] [Abstract][Full Text] [Related]
12. Haplotypes linked to three rare beta-thalassemia mutations, originally reported in Tunisia.
Bibi A; Messaoud T; Fattoum S
Hemoglobin; 2006; 30(2):175-81. PubMed ID: 16798642
[TBL] [Abstract][Full Text] [Related]
13. Nucleotide -88 (C-T) promoter mutation is a common beta-thalassemia mutation in the Jat Sikhs of Punjab, India.
Garewal G; Das R; Ahluwalia J; Marwaha RK; Varma S
Am J Hematol; 2005 Aug; 79(4):252-6. PubMed ID: 16044458
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the genetic basis of phenotypic heterogeneity in north Indian patients with thalassemia major.
Sharma N; Das R; Kaur J; Ahluwalia J; Trehan A; Bansal D; Panigrahi I; Marwaha RK
Eur J Haematol; 2010 Jun; 84(6):531-7. PubMed ID: 20132300
[TBL] [Abstract][Full Text] [Related]
15. Detection of beta-thalassemia mutations using a multiplex amplification refractory mutation system assay.
Mirasena S; Shimbhu D; Sanguansermsri M; Sanguansermsri T
Hemoglobin; 2008; 32(4):403-9. PubMed ID: 18654891
[TBL] [Abstract][Full Text] [Related]
16. Identification of three novel mutations [-41 (A>C), codon 24 (-G), and IVS-I-109 (-T)], in a study of beta-thalassemia alleles in the Isfahan region of Iran.
Salehi R; Fisher CA; Bignell PA; Eslami G; Old JM
Hemoglobin; 2010; 34(1):115-20. PubMed ID: 20113296
[TBL] [Abstract][Full Text] [Related]
17. The molecular analysis of beta-thalassemia mutations in Lorestan Province, Iran.
Kiani AA; Mortazavi Y; Zeinali S; Shirkhani Y
Hemoglobin; 2007; 31(3):343-9. PubMed ID: 17654071
[TBL] [Abstract][Full Text] [Related]
18. The molecular heterogeneity of beta-thalassemia in Greece.
Boussiou M; Karababa P; Sinopoulou K; Tsaftaridis P; Plata E; Loutradi-Anagnostou A
Blood Cells Mol Dis; 2008; 40(3):317-9. PubMed ID: 18096416
[TBL] [Abstract][Full Text] [Related]
19. The clinical severity of beta-thalassemia mutations in West Malaysia.
George E
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():225-8. PubMed ID: 8629111
[TBL] [Abstract][Full Text] [Related]
20. The clinical significance of the spectrum of interactions of CAP+1 (A-->C), a silent beta-globin gene mutation, with other beta-thalassemia mutations and globin gene modifiers in north Indians.
Garewal G; Das R; Awasthi A; Ahluwalia J; Marwaha RK
Eur J Haematol; 2007 Nov; 79(5):417-21. PubMed ID: 17900295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
